6-K/A

AMENDMENT NO.1 TO FORM 6-K

Company: Scinai Immunotherapeutics Ltd.
Filed: August 7, 2024
Period of Report: August 7, 2024
Accession Number: 0001213900-24-066053

View Document ↗ View on SEC.gov ↗